Clinical Trial Update: Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating the efficacy and safety of HS-10234 in patients with chronic hepatitis B infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HS-10234

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic HBV Infection | Phase 3 | Status: COMPLETED